Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck
Benjamin H Kaffenberger1, Jason Mathis2, Matthew J Zirwas3
1Division of Dermatology, Ohio State University College of Medicine, Columbus, Ohio; Ohio State University College of Medicine, Columbus, Ohio.
Background:
Head and neck dermatitis is a subtype of atopic dermatitis driven by Malassezia yeast.
Objective:
We sought to evaluate the response of these patients to systemic azole antifungals.
Methods:
We queried the electronic medical records from our institution for patients that were referred for allergy patch testing, were ultimately given the diagnosis of head and neck dermatitis, and were treated with oral azole antifungals over a 2-year period.
Results:
Twenty-four patients met inclusion criteria and were analyzed. Most patients noted their characteristic flare beginning during their teenage, young adult, or adult years. All were noted to have some involvement of the head and neck, and 17 responded to treatment. The mean time taking an azole antifungal medication was 8 months, with a mean overall follow-up of 10 months.
Limitations:
This was a retrospective descriptive study, from a single institution, of a limited number of patients, and did not use a validated scoring system.
Conclusion:
Itraconazole and other azole antifungals were an effective treatment for more than two-thirds of adult patients with head and neck predominant atopic dermatitis.
Insights
Systemic azole antifungals effectively treated head and neck dermatitis in adults. Over two-thirds of patients experienced symptom improvement, demonstrating the efficacy of this treatment approach.
Area of Science:
- Dermatology
- Mycology
- Internal Medicine
Background:
- Head and neck dermatitis is a specific form of atopic dermatitis.
- This condition is primarily caused by Malassezia yeast infections.
Purpose of the Study:
- To assess the effectiveness of systemic azole antifungal medications.
- To evaluate treatment outcomes for patients diagnosed with head and neck dermatitis.
Main Methods:
- Retrospective analysis of electronic medical records.
- Inclusion criteria: diagnosis of head and neck dermatitis and treatment with oral azole antifungals.
- Study period: 2 years, involving 24 patients.
Main Results:
- 17 out of 24 patients (over two-thirds) showed a positive response to azole antifungal treatment.
- Patients' characteristic flares often began in adolescence or early adulthood.
- Average treatment duration was 8 months, with a 10-month follow-up period.
Conclusions:
- Systemic azole antifungals, including itraconazole, are effective for treating head and neck atopic dermatitis in adults.
- The study highlights a significant treatment response in a majority of patients.
- Limitations include the retrospective nature and small sample size from a single institution.
Related Concept Videos
Antifungal Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

